you had enron ceo telling it workers to buy more while the ship was burning.... then you have orwin ceo affy saying the drug doesn't work when it works on 99.98% of people.epogen is no better then omontys it had problems to smells fish to me
So you say Epogen is no better than Omontys. Your post smells like fish to me. Let's see what others have to say about Epogen compared to Omontys, from a NY Times article published shortly after the Omontys recall:
Dr. Daniel W. Coyne, a kidney specialist at Washington University in St. Louis, said that unless the problem was because of contamination, “this could easily lead to withdrawal of drug approval.” He said that “two in 10,000 deaths on first exposure is unacceptable, compared to nothing like this” with Epogen.
Dr. Ajay K. Singh, a kidney specialist at Brigham and Women’s Hospital in Boston, said that the recall should result in “minimal disruption” because centers could use Epogen or another Amgen drug, Aranesp. But he said it might be hard for Affymax and Takeda, which is based in Osaka, to show the safety of their drug without a huge study.